Literature DB >> 21517654

Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty.

Onur Baser1.   

Abstract

Venous thromboembolism (VTE) is a common complication following total hip arthroplasty or total knee arthroplasty and can lead to morbidity and mortality, as well as considerable healthcare costs. However, the incidence of VTE can be greatly minimized with effective thromboprophylaxis administered for the appropriate period of time. While guidelines exist to assist clinicians in determining what type of thromboprophylaxis should be prescribed and for how long, those guidelines are frequently not followed. Prevention of VTE would improve patient outcomes and result in substantial savings to payers and providers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517654

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

Review 1.  Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

2.  Incidence, characteristics, and risk factors of venous thromboembolism in shoulder arthroplasty-a systematic review.

Authors:  Sang-Soo Na; Du-Han Kim; Byung-Chan Choi; Chul-Hyun Cho
Journal:  Int Orthop       Date:  2022-06-28       Impact factor: 3.479

3.  Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.

Authors:  Yong Yang; Gangning Feng; Jiangbo Yan; Long Wu; Faxuan Wang; Dong Ding; Hui Wang; Qunhua Jin
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

Review 4.  Incidence and risk factors for venous thromboembolism following surgical treatment of fractures below the hip: a meta-analysis.

Authors:  Lei Tan; Baochang Qi; Tiecheng Yu; Chengxue Wang
Journal:  Int Wound J       Date:  2016-03-02       Impact factor: 3.315

Review 5.  Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years.

Authors:  Zi-hao Zhang; Bin Shen; Jing Yang; Zong-ke Zhou; Peng-de Kang; Fu-xing Pei
Journal:  BMC Musculoskelet Disord       Date:  2015-02-10       Impact factor: 2.362

6.  Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist.

Authors:  Luke Bamber; Dominic Muston; Euan McLeod; Anne Guillermin; Julia Lowin; Raj Patel
Journal:  Thromb J       Date:  2015-06-11

7.  Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment.

Authors:  Vincent Ten Cate; Brigitte Ab Essers; Martin H Prins
Journal:  BMJ Open       Date:  2017-05-10       Impact factor: 2.692

8.  Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study.

Authors:  Donglin Fu; Li Li; Yifan Li; Xiaofei Liu; Hongkang Chen; Naitian Wu; Guangfeng Sun
Journal:  BMC Surg       Date:  2022-06-24       Impact factor: 2.030

9.  Is aspirin still relevant as a single pharmacological agent for venous thromboembolism prophylaxis post hip and knee arthroplasty surgery: A retrospective review.

Authors:  Jacques Pretorius; Nouman Nemat; Imran Azeem; Tony Shaju; Sayed Nadeem; Yasir Hammad
Journal:  SICOT J       Date:  2022-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.